Literature DB >> 11061652

Influence of CCR5 promoter haplotypes on AIDS progression in African-Americans.

P An1, M P Martin, G W Nelson, M Carrington, M W Smith, K Gong, D Vlahov, S J O'Brien, C A Winkler.   

Abstract

OBJECTIVES: To test the hypothesis that the CCR5 promoter variants in HIV-1-infected African-Americans affect the rate of progression to AIDS and to determine the extent of linkage disequilibrium between the CCR5P1 allele and the CCR5 59029A variant (referred to here as CCR5-2459A), both of which have been shown independently to accelerate AIDS progression in Caucasians.
DESIGN: We used survival analysis to assess the effects of CCR5 promoter variants in HIV-1 seroincident Caucasians and African-Americans. SUBJECTS AND METHODS: Genotypes were determined for 806 Caucasians and 1067 African-Americans, which included 700 seroconverters, enrolled in four HIV/AIDS natural history cohort studies. These genotypes were used to determine linkage and haplotypes for CCR2 and CCR5 alleles. Survival analysis was used to assess the effect of CCR2, CCR5, and CCR5 promoter haplotypes on progression to AIDS in seroincident African-Americans.
RESULTS: A survey of Caucasians and African-Americans demonstrated complete linkage disequilibrium between CCR5P1 and CCR5-2459A sites. The composite CCR5P1 haplotype (including the CCR5-2459A allele) is shown to be associated with rapid progression to AIDS endpoints in both African-American and Caucasian cohorts, but the effect is recessive in Caucasians and dominant in African-Americans. This is probably due to the presence of modulating genes or as yet unidentified polymorphisms that may differ between racial groups.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11061652     DOI: 10.1097/00002030-200009290-00007

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  22 in total

1.  CCR5 promoter polymorphism determines macrophage CCR5 density and magnitude of HIV-1 propagation in vitro.

Authors:  Janelle R Salkowitz; Shannon E Bruse; Howard Meyerson; Hernan Valdez; Donald E Mosier; Clifford V Harding; Peter A Zimmerman; Michael M Lederman
Journal:  Clin Immunol       Date:  2003-09       Impact factor: 3.969

2.  Distribution of chemokine receptor CCR2 and CCR5 genotypes and their relative contribution to human immunodeficiency virus type 1 (HIV-1) seroconversion, early HIV-1 RNA concentration in plasma, and later disease progression.

Authors:  Jianming Tang; Brent Shelton; Nina J Makhatadze; Yuting Zhang; Margaret Schaen; Leslie G Louie; James J Goedert; Eric C Seaberg; Joseph B Margolick; John Mellors; Richard A Kaslow
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

Review 3.  Host genes associated with HIV/AIDS: advances in gene discovery.

Authors:  Ping An; Cheryl A Winkler
Journal:  Trends Genet       Date:  2010-02-10       Impact factor: 11.639

4.  CCR5 promoter haplotypes differentially influence CCR5 expression on natural killer and T cell subsets in ethnically divergent HIV-1 uninfected South African populations.

Authors:  Anabela C P Picton; Maria Paximadis; Caroline T Tiemessen
Journal:  Immunogenetics       Date:  2012-08-15       Impact factor: 2.846

5.  Role of chemokine and cytokine polymorphisms in the progression of HIV-1 disease.

Authors:  Supriya D Mahajan; Anardi Agosto-Mojica; Ravikumar Aalinkeel; Jessica L Reynolds; Bindukumar B Nair; Donald E Sykes; Jeffery Martinez; Joshua Adams; Neha Singh; Zale Bernstein; Chiu-bin Hsiao; Stanley A Schwartz
Journal:  Biochem Biophys Res Commun       Date:  2010-04-21       Impact factor: 3.575

6.  Association of host genetic risk factors with the course of cytomegalovirus retinitis in patients infected with human immunodeficiency virus.

Authors:  Efe Sezgin; Mark L van Natta; Alka Ahuja; Alice Lyon; Sunil Srivastava; Jennifer L Troyer; Stephen J O'Brien; Douglas A Jabs
Journal:  Am J Ophthalmol       Date:  2011-03-10       Impact factor: 5.258

7.  Genetic protection against hepatitis B virus conferred by CCR5Delta32: Evidence that CCR5 contributes to viral persistence.

Authors:  Chloe L Thio; Jacquie Astemborski; Arman Bashirova; Timothy Mosbruger; Spencer Greer; Mallory D Witt; James J Goedert; Margaret Hilgartner; Audrey Majeske; Stephen J O'Brien; David L Thomas; Mary Carrington
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

Review 8.  Role of HIV Gp41 mediated fusion/hemifusion in bystander apoptosis.

Authors:  H Garg; R Blumenthal
Journal:  Cell Mol Life Sci       Date:  2008-10       Impact factor: 9.261

9.  Modulating influence on HIV/AIDS by interacting RANTES gene variants.

Authors:  Ping An; George W Nelson; Lihua Wang; Sharyne Donfield; James J Goedert; John Phair; David Vlahov; Susan Buchbinder; William L Farrar; William Modi; Stephen J O'Brien; Cheryl A Winkler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-11       Impact factor: 11.205

10.  Characterisation of SNP haplotype structure in chemokine and chemokine receptor genes using CEPH pedigrees and statistical estimation.

Authors:  Vanessa J Clark; Michael Dean
Journal:  Hum Genomics       Date:  2004-03       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.